Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors
Clinical trial NCT00519662 · COMPLETED
Trial details
- NCT number
- NCT00519662
- Sponsor
- Sunesis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-03-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.